Genome-Edited Cell-Derived Peptide Signatures as Biomarkers of Therapeutic Product Identity

Speciality: Gene & Cell Therapy


Speaker:

Kumari Monika Yadav | HCP

Description:

Welcome to our podcast. Today, we explore how genome-edited cell-derived peptide signatures are emerging as powerful biomarkers for therapeutic product identity. In cell therapies, ensuring the consistency and safety of the final product is critical. Genome editing, like CRISPR, can introduce specific changes in cells, and these modifications often lead to unique peptide signatures—short protein fragments that act like molecular fingerprints. By analysing these peptides, scientists can confirm the identity and purity of the therapeutic product with greater accuracy than ever before. This advancement not only enhances quality control but also builds trust in innovative cell-based treatments. Stay tuned as we continue to unpack the future of precision medicine.

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer during young adulthood carries long-term mental toll, study finds

2.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

3.

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot